articles2020-07-28T11:39:10+00:00

PUBLICATIONS

Articles

MCDA in a hospital pharmacy and therapeutics committee

May 1st, 2018|

Multi-Criteria Decision Analysis as a Decision-support tool for Drug Evaluation: A Pilot Study in a Pharmacy and Therapeutics Comittee Setting. Avaliable at: https://www.cambridge.org/ [...]

Burden of Acromegaly

February 23rd, 2018|

Patient-centered assessment on disease burden, quality of life, and treatment satisfaction associated with acromegaly Available at: https://jim.bmj.com/content/66/3/653.long [...]

Quality of life questionnaire in Acromegaly

October 23rd, 2017|

Mapping AcroQoL scores to EQ-5D to obtain utility values for patients with acromegaly Avaliable at: https://www.tandfonline.com/doi/full/10.1080/13696998.2017.1419960 [...]

ACRODAT® software for Acromegaly

September 8th, 2017|

Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly Available at: https://link.springer.com/article/10.1007/s11102-017-0835-5 [...]

MCDA framework in Catalonia for Orphan Drugs

April 24th, 2017|

Drug Evaluation and Decision Making in Catalonia: Development and Validation of a Methodological Framework Based on Multi-Criteria Decision Analysis (MCDA) for Orphan Drugs. Avaliable [...]

Load More Posts

This website uses cookies so that you have the best user experience. If you continue browsing you are giving your consent for the acceptance of the aforementioned cookies and the acceptance of our cookies policy, Click on the link for more information. ACEPTAR

Aviso de cookies